Arrakis Bio
Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.
About
Technology stack
detected 2026-06-10No comments yet. Be the first to share your take.
What does Arrakis Bio do?
Arrakis Bio bio-manufactures regenerative human biomaterials, starting with medical-grade human collagen. Their proprietary technology enables sustainable, scalable production of high-purity collagen for medical aesthetics, regenerative medicine, and biomedical research. Arrakis Bio aims to revolutionize the availability of these advanced biomaterials for a healthier and more beautiful future.
Where is Arrakis Bio headquartered?
Arrakis Bio is headquartered in Cambridge, United States.
When was Arrakis Bio founded?
Arrakis Bio was founded in 2019.
What industry does Arrakis Bio operate in?
Arrakis Bio operates in Life Sciences, Agritech, Food, Biotech, MedTech, HealthTech.
How many employees does Arrakis Bio have?
Arrakis Bio has approximately 5 people on record.